Role of endocannabinoids in brain development

Life Sciences

Volumn 65, Issue 6-7, 1999, Pages 725-736

  Fernandez Ruiz J J ^a   Berrendero, F ^a   Hernandez M L ^a   Romero, J ^a   Ramos, J A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Brain development; Cannabinoid receptors; Endogenous cannabinoids

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; DOPAMINE; DRONABINOL; MESSENGER RNA; NEUROTRANSMITTER; OPIATE PEPTIDE; RIMONABANT; SEROTONIN; STEROID;

ARTICLE; BRAIN; BRAIN DEVELOPMENT; GENE EXPRESSION; HUMAN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ANIMALS; BEHAVIOR; BRAIN; CANNABINOIDS; CELLS, CULTURED; ENDOCANNABINOIDS; FEMALE; HUMANS; NEUROTRANSMITTER AGENTS; PREGNANCY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

CANNABIS;

EID: 0033538483     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00295-7     Document Type: Article

References (85)

1. R. Mechoulam, L. Hanus and B.R. Martin, Biochem. Pharmacol. 48 1537-1544 (1994).
2. R.G. Pertwee, In: Cannabinoid Receptors (ed. Pertwee R.G.), pp 1-34. Academic Press, London (1995).
3. S.R. Childers and C.S. Breivogel, Drug Alcoh. Depend. 51 173-187 (1998).
4. V. Di Marzo, D. Melck, T. Bisogno and L. De Petrocellis, Trends Neurosci. 21 521-528 (1998).
5. M. Herkenham, A.B. Lynn, M.D. Little, M.R., Johnson, L.S. Melvin, D.R. De Costa and K.C. Rice, PNAS (USA) 87 1932-1936 (1990).
6. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. De Costa and K.C. Rice, J. Neurosci. 11 563-583 (1991).
7. P. Mailleux and J.J. Vanderhaeghen, Neuroscience 48 655-668 (1992).
8. A.C. Howlett, Ann. Rev. Pharmacol. Toxicol. 35 607-634 (1995).
9. R.G. Pertwee, Pharmacol. Ther. 74 129-180 (1997).
10. M. Glass, J.M. Brotchie and Y.P. Maneuf, Eur. J. Neurosci. 9 199-203 (1997).
11. M.E. Abood and B.R. Martin, Trends Pharmacol. Sci. 13 201-205 (1992).
12. T.U. Jarbe and D.A. Mathis, NIDA Res. Monogr. 116 75-99 (1991).
13. J.J. Fernandez-Ruiz, F. Rodriguez de Fonseca, M. Navarro and J.A. Ramos, In: Neurobiology and Neurophysiology of Cannabinoids, Biochemistry and Physiology of Substance Abuse, vol. IV (Bartke, A. and Murphy, L.L., eds.), pp. 119-164, CRC Press, Boca Raton, FL (1992).
14. J.J. Fernandez-Ruiz, A. Bonnin, M. Cebeira and J.A. Ramos, In: Strategies for Studying Brain Disorders, vol. 1. (Palomo, T. and Archer, T., eds.), pp. 357-390, Farrand Press, England (1994).
15. J.J. Fernandez-Ruiz, J. Romero, L. Garcia-Gil, E. Garcia-Palomero and J.A. Ramos, In: Dopamine Disease States (Beninger, R.J., Archer, T. and Palomo, T., eds.), pp. 359-387, CYM Press, Madrid, Spain (1996).
16. F. Berrendero, L. Garcia-Gil, M.L. Hernandez, J. Romero, M. Cebeira, R. de Miguel, J.A. Ramos and J.J. Fernandez-Ruiz, Development 125 3179-3188 (1998).
17. A. Bonnin, R. de Miguel, J.C. Rodriguez-Manzaneque, J.J. Fernandez-Ruiz, A. Santos and J.A. Ramos, Dev. Brain Res. 81 147-150 (1994).
18. A. Bonnin, R. de Miguel, J.G. Castro, J.A. Ramos and J.J. Fernandez-Ruiz, Mol. Neurosci. 7 291-308 (1996).
19. S.L. Dalterio, Neurobehav. Toxicol. Teratol. 8 345-352 (1986).
20. A.M. Kumar, M. Haney, T. Becker, M.L. Thompson, R.M. Kream and K. Miczek, Brain Res. 525 78-83 (1990).
21. F. Molina-Holgado, A. Amaro, M.I. Gonzalez, F.J. Alvarez and M.L. Leret, Eur. J. Pharmacol. 316 39-42 (1996).
22. F. Rodriguez de Fonseca, M. Cebeira, J.J. Fernandez-Ruiz, M. Navarro and J.A. Ramos, Neuroscience 43 713-723 (1991).
23. D.E. Walters and L.A. Carr, Pharmacol. Biochem. Behav. 25 763-778 (1986).
24. D.E. Walters and L.A. Carr, Pharmacol. Biochem. Behav. 29 213-216 (1988).
25. G.G. Nahas, In: Marihuana in Science and Medicine (Nahas, G.G., ed.), pp. 102-247, Raven Press, New York (1984).
26. M. Navarro, F. Rodriguez de Fonseca, M.L. Hernandez, J.A. Ramos and J.J. Fernandez-Ruiz, Pharmacol. Biochem. Behav. 47 47-58 (1994).
27. M. Navarro, R. de Miguel, F. Rodriguez de Fonseca, J.A. Ramos and J.J. Fernandez-Ruiz, Behav. Brain Res. 75 91-98 (1996).
28. L. Garcia-Gil, R. de Miguel, J.A. Ramos and J.J. Fernandez-Ruiz, Drug Alcoh. Depend. 42 155-166 (1996).
29. L. Garcia-Gil, J.A. Ramos, T. Rubino, D. Parolaro and J.J. Fernandez-Ruiz, Neurotoxicol. Teratol. 20 549-553 (1998).
30. L. Garcia-Gil, R. de Miguel, J. Romero, A. Perez, J.A. Ramos and J.J. Fernandez-Ruiz, Neurotoxicol. Teratol. (in press, 1999).
31. J. Corchero, L. Garcia-Gil, J. Manzanares, J.J. Fernandez-Ruiz, J.A. Fuentes and J.A. Ramos, Life Sci. 63 843-850 (1998).
32. G. Vela, J.A. Fuentes, A. Bonnin, J.J. Fernandez-Ruiz and M. Ruiz-Gayo, Brain Res. 680 142-147 (1995).
33. G. Vela, S. Martin, L. Garcia-Gil, J.A. Crespo, M. Ruiz-Gayo, J.J. Fernandez-Ruiz, C. Garcia-Lecumberri, D. Pelaprat, J.A. Fuentes, J.A. Ramos and E. Ambrosio, Brain Res. 807 101-109 (1998).
34. S.L. Dalterio, Pharmacol. Biochem. Behav. 12 143-153 (1980).
35. D.A. Mokler, S.E. Robinson, J.H. Johnson, J.S. Hong and J.A. Rosecrans, Neurotoxicol. Teratol. 9 321-326 (1987).
36. S. Dalterio and A. Bartke, Science 205 420-1422 (1979).
37. L.L. Murphy, R.W. Steger and A. Bartke, In: Biochemistry and Physiology of Substance Abuse, vol. 2 (Watson, R.R., ed.), pp. 73-94, CRC Press, Boca Ratón, FL (1990).
38. R.C. Belue, A.C. Howlett, T.M. Westlake and D.E. Hutchings, Neurotoxicol. Teratol. 7 25-30 (1995).
39. C.R. McLaughlin and M.E. Abood, Dev. Brain Res. 76 75-78 (1993).
40. C.R. McLaughlin, B.R. Martin, D.R. Compton and M.E. Abood, Drug Alcohol Depend. 36 27-31 (1994).
41. P. Mailleux and J.J. Vanderhaeghen, Neurosci. Lett. 148 173-176 (1992).
42. F. Rodriguez de Fonseca, J.A. Ramos, A. Bonnin and J.J. Fernandez-Ruiz, Neuroreport 4 135-138 (1993).
43. J. Romero, E. Garcia-Palomero, F. Berrendero, L. Garcia-Gil, M.L. Hernandez, J.A. Ramos and J.J. Fernandez-Ruiz, Synapse 26 317-323 (1997).
44. F. Berrendero, N. Sepe, J.A. Ramos, V. Di Marzo and J.J. Fernandez-Ruiz, Synapse (in press, 1999).
45. N.E. Buckley, S. Hansson, G. Harta and E. Mezey, Neuroscience 82 1131 -1149 (1998).
46. M. Glass, M. Dragunow and R.L.M. Faull, Neuroscience 77 299-318 (1997).
47. M. Bouaboula, B. Bourrie, M. Rinaldi-Carmona, D. Shire, G. Le Fur and P. Casellas, J. Biol. Chem. 270 13973-13980 (1995).
48. A.C. Shivachar, B.R. Martin and E.F. Ellis, Biochem. Pharmacol. 51 669-676 (1996).
49. C. Sanchez, I. Galve, D. Rueda and M. Guzman, Mol. Pharmacol. 54 834-843 (1998).
50. M.L. Hernandez, L. Garcia-Gil, F. Berrendero, J.A. Ramos and J.J. Fernandez-Ruiz, J. Mol. Neurosci. 8 83-91 (1997).
51. M.L. Hernandez, F. Berrendero, L. Garcia-Gil, M. Cebeira, I. Suarez, J.G. Castro, J.A. Ramos and J.J. Fernandez-Ruiz, J. Neurochem. (in press, 1999).
52. N.L. Day, G.A. Richardson, L. Goldschmidt, N. Robles, P.M. Taylor, D.S. Stoffer, M.D. Cornelius and D. Geva, Neurotoxicol. Teratol. 16 169-175 (1994).
53. P.A. Fried, Life Sci. 56 2159-2168 (1995).
54. E.G. Adams, J.C. Gfroerer and B.A. Rouse, Ann. NY Acad. Sci. 562 123-132 (1989).
55. M. Mirmiran and D.F. Swaab, Dev. Pharmacol. Ther. 10 377-384 (1987).
56. E. Fride and R. Mechoulam, Psychoneuroendocrinol. 21 157-172 (1996).
57. E. Fride and R. Mechoulam, Dev. Brain Res. 95 131-134 (1996).
58. L. Garcia-Gil, J.G. Castro, A. Bonnin, R. de Miguel, J.A. Ramos and J.J. Fernandez-Ruiz, Arquiv. Med. 12 141-146 (1998).
59. P. Rubio, F. Rodriguez, J.L. Martin-Calderon, I. del Arco, S. Bartolome, M.A. Villanua and M. Navarro, Pharmacol. Biochem. Behav. 61 229-238 (1998).
60. G.F. Kawash, D.L. Yeung and S.D. Berg, Percept. Motor Skills 50 359-365 (1980).
61. J.J. Fernandez-Ruiz, A. Bonnin. R. de Miguel, J.G. Castro and J.A. Ramos, Arquiv. Med. 12 67-77 (1998).
62. F. Molina-Holgado, F.J. Alvarez, I. Gonzalez, M.T. Antonio and M.L. Leret, Brain Res. Bull. 43 173-178 (1997).
63. L.A. Specht, W.M. Pickel, T.H. Jooh and D.J. Reis, J. Comp. Neurol. 199 233-245 (1981).
64. B. Berger, C. Verney, P. Gaspar and A. Febvret, Dev. Brain Res. 23 141-147 (1987).
65. P. Levitt, J.A. Harvey, E. Friedman, K. Simansky and E.H. Murphy, Trends Neurosci. 20 269-274 (1997).
66. E.L. Gardner, In: Neurobiology and Neurophysiology of Cannabinoids, Biochemistry and Physiology of Substance Abuse, vol. IV (Bartke, A. and Murphy, L.L., eds.), pp. 275-335, CRC Press, Boca Raton, FL (1992).
67. T.R. Insel, In: Psychopharmacology: The Fourth Generation of Progress (Bloom F.E. and Kupfer D.J., eds.), pp. 683-694, Raven Press, New York (1995).
68. A. Bonnin, R. de Miguel, M.L. Hernandez, J.A. Ramos and J.J. Fernandez-Ruiz, Life Sci. 56 2177-2184 (1995).
69. I. Suarez, G. Bodega, J.A. Ramos, J.J. Fernandez-Ruiz and B. Fernandez, Neurotoxicol. Teratol. (in press, 1999).
70. L. Garcia-Gil, J. Romero, J.A. Ramos and J.J. Fernandez-Ruiz, Drug Alcoh. Depend. (in press, 1999).
71. M. Herkenham, A. Lynn, B. de Costa and E. Richfield, Brain Res. 547 267-274 (1991).
72. M.A. Pacheco, S.J. Ward and S.R. Childers, Brain Res. 603 102-110 (1993).
73. J. Romero, E. Garcia-Palomero, J.J. Fernandez-Ruiz and J.A. Ramos, Behav. Pharmacol. 7 299-302 (1996).
74. J.M. Lauder, Psychoneuroendocrinol. 8 121-128 (1983).
75. N. Pares-Herbute, L. Tapia-Arancibia and H. Artier, Int. J. Dev. Neurosci. 7 73-79 (1989).
76. S. Martin, J. Manzanares, J. Corchero, C. Garcia-Lecumberri, J.A. Crespo, J.A. Fuentes and E. Ambrosio, Brain Res. 821 350-355 (1999).
77. P. Rubio, F. Rodriguez de Fonseca, R.M. Muñoz, C. Ariznavarreta, J.L. Martin-Calderon and M. Navarro, Life Sci. 56 2169-2176 (1995).
78. K. Tsou, S.L. Patrick and J.M. Walker, Eur. J. Pharmacol. 280 R13-R15 (1995).
79. M.D. Aceto, S.M. Scates, J.A. Lowe and B.R. Martin, Eur. J. Pharmacol. 282 R1-R2 (1995).
80. A.C. Howlett, M. Bidaut-Russell, W.A. Devane, L.S. Melvin, M.R. Johnson and M. Herkenham, Trends Neurosci. 13 420-423 (1990).
81. M. Jacobson, Developmental Neurobiology. Plenum Press, New York, USA (1993).
82. M. Nedergaard, Science 263 1768-1771 (1994).
83. C. Sanchez, G. Velasco and M. Guzman, Brain Res. 767 64-71 (1997).
84. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz and D. Piomelli, Nature 372 686-691 (1994).
85. L. Venance, D. Piomelli, J. Glowinski and C. Giaume, Nature 376 590-594 (1995).